The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1b/2a study of safety and efficacy of NT-I7 in combination with anti-PD-L1 (atezolizumab) in patients with anti-PD-1/PD-L1 naïve or relapsed/refractory (R/R) high-risk skin cancers: The phase 1b report.
 
Brian Gastman
Stock and Other Ownership Interests - Castle Biosciences
Consulting or Advisory Role - Castle Biosciences; Quest Imaging
Speakers' Bureau - Castle Biosciences
Research Funding - Alkermes; Instil Bio; Merck; NeoImmuneTech; Quest Imaging
Travel, Accommodations, Expenses - Alkermes
 
Steven Fling
Research Funding - Alkermes (Inst); Genentech (Inst); Merck (Inst); NeoImmuneTech (Inst)
 
George Ansstas
Consulting or Advisory Role - Novartis
Research Funding - Novocure
 
Pauline Funchain
Consulting or Advisory Role - Eisai; GigaGen; Novartis
Research Funding - Bristol-Myers Squibb (Inst); Pfizer (Inst); Taiho Oncology (Inst)
 
Ann W. Silk
Consulting or Advisory Role - Genzyme; Instil Bio; Merck; Oncosec
Research Funding - Biohaven Pharmaceuticals (Inst); Morphogenesis (Inst); Replimune (Inst); Shattuck Labs (Inst)
 
Philip Adam Friedlander
Stock and Other Ownership Interests - Adverum; allergan; Clovis Oncology; Gilead Sciences; Incyte; Iovance Biotherapeutics; Thermo Fisher Scientific
Consulting or Advisory Role - Castle Biosciences; DBV Technologies; regeneron
Research Funding - Amgen; Idera; Kartos Therapeutics; Merck; Novartis; Regeneron
Travel, Accommodations, Expenses - Castle Biosciences; Regeneron
 
Brendan D. Curti
Honoraria - Clinigen Group; Nektar
Consulting or Advisory Role - Merck
Research Funding - Bristol-Myers Squibb (Inst); Clinigen Group (Inst); Galectin Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Biomarkers for OX40 response (Inst)
Travel, Accommodations, Expenses - Agonox
 
Yan Xing
No Relationships to Disclose
 
Oanh Nguyen
No Relationships to Disclose
 
Ann Christensen
No Relationships to Disclose
 
Sara Ferrando-Martinez
Employment - AstraZeneca/MedImmune; NeoImmuneTech
 
Andreanne Lacroix
Research Funding - Genentech (Inst); NeoImmuneTech (Inst)
 
Byung Ha Lee
Employment - NeoImmuneTech
Stock and Other Ownership Interests - NeoImmuneTech
Patents, Royalties, Other Intellectual Property - One Filed patent but not granted, yet.
Travel, Accommodations, Expenses - NeoImmuneTech
 
David M. Miller
Stock and Other Ownership Interests - Checkpoint Therapeutics
Consulting or Advisory Role - Castle Biosciences; Checkpoint Therapeutics; Merck Sharp & Dohme; Pfizer/EMD Serono; Regeneron; Sanofi/Regeneron
Research Funding - Incyte
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Pfizer; Regeneron; Sanofi/Aventis
 
Jeffrey A. Sosman
Honoraria - Apexian Pharmaceuticals; Array BioPharma; Bristol-Myers Squibb; Iovance Biotherapeutics; Jazz Pharmaceuticals
Consulting or Advisory Role - Apexigen; Array BioPharma; Bristol-Myers Squibb; Iovance Biotherapeutics; Jazz Pharmaceuticals
 
Jean Fan
Employment - NeoImmuneTech
Leadership - NeoImmuneTech
Stock and Other Ownership Interests - AstraZeneCa, NeoImmuneTech, Inc